Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Insufficient |
In the current state of the dossier and while awaiting the results of the VEG 108844 non-inferiority study comparing VOTRIENT with sunitinib, the Transparency Committee considers that the actual benefit is insufficient to justify reimbursement by National Health Insurance. |
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
QjKNyU7bMph9St1w
